Long arginine 3-IGF-1, commonly referred to as IGF-1 LR3 or LR3-IGF-1, is a synthetic protein that is a modified form of human insulin-like growth factor 1 (IGF-1).
IGF
Active Substance: Long-R3 IGF-1 Also Known As: Long-R3 IGF-1, IGF, Long arginine 3-IGF-1 Active Half-Life20-30 hours Effects of IGF: The latest formulation of this product is Long-R3 IGF-1, which has been chemically refined and altered with amino acid modifications, allowing it to evade binding with proteins in the body and enabling a significantly extended half-life of approximately 20-30 hours. Igtropin (Long-R3 IGF-1) is utilized to enhance amino acid transportation in cells, promote glucose uptake, increase protein synthesis, reduce protein breakdown, and stimulate RNA synthesis. When Igtropin (Long-R3 IGF-1) is active, it operates differently across various types of tissues; in muscle cells, it stimulates proteins and associated cellular components. This substance is crucial for muscle enhancement. Igtropin (Long-R3 IGF-1) promotes both the proliferation and differentiation of stem cells through an autocrine and paracrine mode, significantly enhancing differentiation. When administered locally, it boosts satellite cell activity, muscle DNA synthesis, protein content, muscle mass, and cross-sectional area. The importance of Igtropin (Long-R3 IGF-1) lies in its ability to stimulate muscle growth, with or without additional physical effort, but it is particularly effective when combined with muscle-loading exercises. This medication enhances protein production and increases the uptake of amino acids as an energy source while also mobilizing fat for energy use in adipose tissues. In lean muscle, Igtropin (Long-R3 IGF-1) prevents insulin from facilitating glucose transport into cells, prompting the cells to utilize fat as an energy source. Additionally, this drug mimics insulin within the body, enhancing muscle sensitivity to insulin, meaning that patients currently on insulin may be able to significantly reduce their dosage while still achieving the desired effects; moreover, Igtropin (Long-R3 IGF-1) helps prevent insulin-related weight gain. Perhaps the most intriguing and powerful effect of this substance is its capacity to induce hyperplasia, which refers to the actual increase in the number of cells. In contrast, hypertrophy is an increase in the size of muscle cells and is commonly associated with weight training. Following puberty, individuals typically have a fixed number of muscle cells, and the only enhancement possible is in their size; however, this treatment can promote hyperplasia, thereby increasing the total number of muscle cells present, which can be further developed through intensive training. In essence, this medication may alter genetic characteristics by potentially increasing an individual's capacity for greater muscle density and size.
possible joint pain, muscle pain, headaches, nausea, and hypoglycemia.
Side Effects:
Usage Guidelines:
IGF-1 Long R3 is recommended for optimal results at a dosage of 100-140 mcg per day. A typical treatment cycle lasts between 4-6 weeks, with daily doses divided into two injections post-exercise. Following a treatment regimen, a break should be taken for at least the same duration to reduce the risk of antibody development and prevent the body from becoming accustomed to IGF-1 Long R3.
